Documents

Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Event/report

Event date

Documents and forms

2026

Q2 2026

Oct 30, 2025

Interim report

Slides

Q1 2026

Jul 30, 2025

Interim report

Slides

Transcript

2025

Study Update

Sep 8, 2025

Press release

Slides

Transcript

Status Update

Jun 1, 2025

Slides

Transcript

Q4 2025

May 8, 2025

Annual report20-F

Interim report

Slides

Transcript

Study Update

Apr 2, 2025

Slides

Transcript

Q3 2025

Jan 30, 2025

Interim report

Slides

Transcript

Q2 2025

Oct 31, 2024

Interim report

Slides

Q1 2025

Jul 31, 2024

Interim report

Slides

2024

Status Update

Dec 12, 2024

Slides

Study Update

Jun 4, 2024

Press release

Q4 2024

May 9, 2024

Annual report20-F

Interim report

Slides

Q3 2024

Feb 1, 2024

Interim report

Slides

Q2 2024

Oct 26, 2023

Interim report

Slides

Q1 2024

Jul 27, 2023

Interim report

Slides

2023

Q4 2023

May 11, 2023

Annual report20-F

Interim report

Slides

Investor Update

Mar 18, 2023

Slides

Investor Update

Mar 15, 2023

Slides

Q3 2023

Feb 2, 2023

Report

Slides

Q2 2023

Oct 27, 2022

Interim report

Slides

Q1 2023

Jul 28, 2022

Interim report

Slides

2022

M&A Announcement

Dec 13, 2022

Slides

Q4 2022

May 11, 2022

Annual report20-F

Interim report

Slides

Q3 2022

Feb 3, 2022

Interim report

Slides

Study Update

Jan 10, 2022

Slides

Q2 2022

Oct 28, 2021

Interim report

Slides

Q1 2022

Jul 30, 2021

Report

Slides

2021

Investor Update

Nov 17, 2021

Slides

Q4 2021

May 11, 2021

Annual report20-F

Interim report

Slides

Takeda Pharmaceutical Co. Ltd.

Documents